Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance

Jul 09, 2019

|

NEW YORK — Celsius Therapeutics said today that it has signed an agreement to help Johnson & Johnson subsidiary Janssen Biotech identify drug response biomarkers for an investigational ulcerative colitis drug combination.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

More Details Wanted

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

And a Third

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Glimpses of Viral Origins

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.

Featured White Papers

Single-cell Sequencing 101: DNA & multi-omics for precision medicine

B Cell Isolation for Single Cell Genomics

Nucleic Acid Contamination Application Ebook

Prevalence of Hereditary Cancer and Benefits of Multi-Gene Panel Testing

Mar

09

Featured Webinar

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

The growth of next-generation sequencing (NGS) testing presents both opportunities and challenges for clinical, informatics, and laboratory teams.

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

16

Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community.

Mar

18

Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Viruses mutate as they strive to thrive in response to selective pressures.

Menu

Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance

To read the full story....

Breaking News

OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate

NanoString Technologies Q4 Revenues Fall 2 Percent

Host DNA Methylation Signatures May Predict Likelihood of Persistent, Resolving MRSA Infections

Seqster, Medable Team on Data Integration for Clinical Trials

FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues

The Scan

More Details Wanted

And a Third

Glimpses of Viral Origins

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More

Featured White Papers

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

What's Popular?

TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine

New Method Provides NGS-Based Readout of Glycan Levels in Single Cells

Personalis to Broaden Liquid Biopsy Footprint With Minimal Residual Disease Testing

Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch

Personal Genome Diagnostics to Build Commercial Infrastructure, Drive Partnerships With New Funding

Sponsorships